MAFTEI, DANIELA
MAFTEI, DANIELA
Dipartimento di Medicina dei sistemi
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy
2024-09-16 Rosina, M; Veltri, F; Nesci, V; Bissacco, J; Bovenzi, R; Mascioli, D; Simonetta, C; Zenuni, H; Maftei, D; Marano, M; Pierantozzi, M; Stefani, A; Chiurchiù, V; Longone, P; Valle, C; Mercuri, Nb; Ferri, A; Schirinzi, T
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease
2021-01-01 Schirinzi, T; Maftei, D; Pieri, M; Bernardini, S; Mercuri, Nb; Lattanzi, R; Severini, C
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction
2023-01-01 Schirinzi, T; Maftei, D; Grillo, P; Bovenzi, R; Bissacco, J; Simonetta, C; Mascioli, D; Zenuni, H; Cerroni, R; Vincenzi, M; Maurizi, R; Passali, Fm; Di Girolamo, S; Ralli, M; Magliulo, G; Tirassa, P; Stefani, A; Mercuri, Nb; Lattanzi, R; Severini, C
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway
2024-01-01 Schirinzi, T; Maftei, D; Maurizi, R; Albanese, M; Simonetta, C; Bovenzi, R; Bissacco, J; Mascioli, D; Boffa, L; Di Certo, Mg; Gabanella, F; Francavilla, B; Di Girolamo, S; Mercuri, Nb; Passali, Fm; Lattanzi, R; Severini, C
Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson’s disease patients independently of APOE
2025-11-01 Mascioli, D; Conti, M; Bissacco, J; Bovenzi, R; Simonetta, C; Buttarazzi, V; Mancini, M; Bagetta, S; Sancesario, Gm; Maftei, D; Veltri, F; Marchionni, E; Stefani, A; Mercuri, Nb; Pieri, M; Schirinzi, T
SGK1 downregulation co-occurs with leukocyte oligomeric α-synuclein accumulation in Parkinson's disease
2026-02-01 Veltri, F; Sancesario, Gm; Rosina, M; Mascioli, D; Bissacco, J; Conti, M; Zenuni, H; Nesci, V; Maftei, D; Buttarazzi, V; Mancini, M; Simonetta, C; Berlizzi, E; Andradi, A; Todaro, F; Chiurchiù, V; Ferri, A; Valle, C; Stefani, A; Mercuri, Nb; Bellia, A; Lauro, D; Schirinzi, T
The Prokineticin System is Downregulated in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Evidence from Olfactory Neurons
2026-01-14 Grillo, P; Maftei, D; Calculli, A; Schirinzi, T; Mauramati, S; Vincenzi, M; Di Certo, Mg; Gabanella, F; Di Martino, D; Benazzo, M; Severini, C; Lattanzi, R; Pisani, A; Terzaghi, M
α‐Synuclein‐Related Mitochondria‐Nrf2 Dysfunction in Parkinson's Disease Olfactory Mucosa
2025-10-01 Maftei, D; Di Certo, Mg; Maurizi, R; Veltri, F; Rosina, M; Bissacco, J; Mascioli, D; Bovenzi, R; Simonetta, C; Mancini, M; Buttarazzi, V; Viola, S; Gravina, A; Maglie, Mg; Rinaldi, Am; Gabanella, F; Saso, L; Stefani, A; Passali, Fm; Di Girolamo, S; Pierantozzi, M; Valle, C; Ferri, A; Mercuri, Nb; Lattanzi, R; Severini, C; Schirinzi, T
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 16-set-2024 | Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy | Rosina, M; Veltri, F; Nesci, V; Bissacco, J; Bovenzi, R; Mascioli, D; Simonetta, C; Zenuni, H; Maftei, D; Marano, M; Pierantozzi, M; Stefani, A; Chiurchiù, V; Longone, P; Valle, C; Mercuri, Nb; Ferri, A; Schirinzi, T | Articolo su rivista | |
| 1-gen-2021 | Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease | Schirinzi, T; Maftei, D; Pieri, M; Bernardini, S; Mercuri, Nb; Lattanzi, R; Severini, C | Articolo su rivista | |
| 1-gen-2023 | Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction | Schirinzi, T; Maftei, D; Grillo, P; Bovenzi, R; Bissacco, J; Simonetta, C; Mascioli, D; Zenuni, H; Cerroni, R; Vincenzi, M; Maurizi, R; Passali, Fm; Di Girolamo, S; Ralli, M; Magliulo, G; Tirassa, P; Stefani, A; Mercuri, Nb; Lattanzi, R; Severini, C | Articolo su rivista | |
| 1-gen-2024 | Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway | Schirinzi, T; Maftei, D; Maurizi, R; Albanese, M; Simonetta, C; Bovenzi, R; Bissacco, J; Mascioli, D; Boffa, L; Di Certo, Mg; Gabanella, F; Francavilla, B; Di Girolamo, S; Mercuri, Nb; Passali, Fm; Lattanzi, R; Severini, C | Articolo su rivista | |
| 1-nov-2025 | Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson’s disease patients independently of APOE | Mascioli, D; Conti, M; Bissacco, J; Bovenzi, R; Simonetta, C; Buttarazzi, V; Mancini, M; Bagetta, S; Sancesario, Gm; Maftei, D; Veltri, F; Marchionni, E; Stefani, A; Mercuri, Nb; Pieri, M; Schirinzi, T | Articolo su rivista | |
| 1-feb-2026 | SGK1 downregulation co-occurs with leukocyte oligomeric α-synuclein accumulation in Parkinson's disease | Veltri, F; Sancesario, Gm; Rosina, M; Mascioli, D; Bissacco, J; Conti, M; Zenuni, H; Nesci, V; Maftei, D; Buttarazzi, V; Mancini, M; Simonetta, C; Berlizzi, E; Andradi, A; Todaro, F; Chiurchiù, V; Ferri, A; Valle, C; Stefani, A; Mercuri, Nb; Bellia, A; Lauro, D; Schirinzi, T | Articolo su rivista | |
| 14-gen-2026 | The Prokineticin System is Downregulated in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Evidence from Olfactory Neurons | Grillo, P; Maftei, D; Calculli, A; Schirinzi, T; Mauramati, S; Vincenzi, M; Di Certo, Mg; Gabanella, F; Di Martino, D; Benazzo, M; Severini, C; Lattanzi, R; Pisani, A; Terzaghi, M | Articolo su rivista | |
| 1-ott-2025 | α‐Synuclein‐Related Mitochondria‐Nrf2 Dysfunction in Parkinson's Disease Olfactory Mucosa | Maftei, D; Di Certo, Mg; Maurizi, R; Veltri, F; Rosina, M; Bissacco, J; Mascioli, D; Bovenzi, R; Simonetta, C; Mancini, M; Buttarazzi, V; Viola, S; Gravina, A; Maglie, Mg; Rinaldi, Am; Gabanella, F; Saso, L; Stefani, A; Passali, Fm; Di Girolamo, S; Pierantozzi, M; Valle, C; Ferri, A; Mercuri, Nb; Lattanzi, R; Severini, C; Schirinzi, T | Articolo su rivista |